Accounting and Valuation Guide: Assets Acquired to Be Used in Research and Development Activities

Accounting and Valuation Guide: Assets Acquired to Be Used in Research and Development Activities

Aicpa.

93,60 €(IVA inc.)

This new guide provides guidance and illustrations regarding the initial and subsequent accounting for, valuation of, and disclosures related to acquired intangible assets used in research and development activities (IPR&D assets). This is a valuable resource for preparers of financial statements, auditors, accountants and valuation specialists seeking an advanced understanding of the accounting, valuation, and disclosures related to acquired IPR&D assets. INDICE: Introduction .01–.11 .History and Organization of This Guide .05–.11 .1 Valuation Techniques Used to Measure Fair Value of In–Process Research and Development Assets .01–.34 .Introduction .01–.05 .Cost Approach .06–.09 .Market Approach .10–.12 .Income Approach .13–.34 .2 Definition of and Accounting for Assets Acquired in a Business Combination That Are to Be Used in Research and Development Activities .01–.68 .Introduction .01–.05 .Key Concepts .06–.38 .Recognition of Assets Acquired in a Business Combination .06–.15 .Attributes of an Acquired IPR&D Project .16–.17 .Unit of Account .18–.24 .Core Technology .25–.27 .Assets Held for Sale .28 .Defensive IPR&D Assets .29–.33 .Temporarily Idled or Abandoned Assets .34–.35 .Completed Intangible Assets Used in R&D Activities .36–.37 .Tangible Assets Used in R&D Activities .38 .Explanatory Comments .39–.68 .Scope of R&D Activities .39–.43 .Specific IPR&D Projects Life Cycle .44–.47 .Specific IPR&D Projects Substance .48–.53 .Specific IPR&D Projects Incompleteness .54–.63 .Questions and Answers Miscellaneous .64–.68 .3 Accounting for Assets Acquired in an Asset Acquisition That Are to Be Used in Research and Development Activities .01–.31 .Introduction .01–.09 .Key Concepts .10–.12 .Key Differences in the Accounting for Asset Acquisitions and Business Combinations .10 .Relevant Accounting Guidance .11–.12 .Explanatory Comments .13–.31 .Alternative Future Use .13–.27 .Questions and Answers Miscellaneous .28–.31 .4 Subsequent Accounting for Acquired Intangible Assets That Are to Be Used in Research and Development Activities .01–.86 .Introduction .01 .Business Combinations .02–.79 .Accounting for Indefinite–Lived IPR&D Assets .10–.31 .Accounting for Assets Resulting From R&D Activities .32–.79 .Income Tax Considerations .80–.82 .Valuation Allowance Assessments .80–.81 .Identifying the Applicable Tax Rate to Calculate Deferred Tax Assets and Liabilities .82 .Additional Considerations for Asset Acquisitions .83–.86 .5 Disclosures of Assets Acquired That Are to Be Used in Research and Development Activities .01–.12 .Business Combinations .01–.07 .Additional Considerations for Asset Acquisitions .08–.12 .Questions and Answers Asset Acquisitions .11–.12 .6 Valuation of In–Process Research and Development Assets .01–.200 .Introduction .01–.02 .Considerations Related to FASB ASC 820 .03–.25 .Overview .03–.05 .Identification of Market Participants .06–.14 .Highest and Best Use for Nonfinancial Assets .15–.25 .Use of Prospective Financial Information .26–.78 .Overview .26–.27 .Steps .28–.78 .Application of the Multiperiod Excess Earnings Method to IPR&D Assets .79–.138 .Overview .79–.81 .Steps .82–.132 .Additional Considerations for the Multiperiod Excess Earnings Method .133–.136 .Illustrative Example: Multiperiod Excess Earnings Method .137–.138 .Application of Relief From Royalty to IPR&D Assets .139–.153 .Overview .139–.141 .Steps .142–.151 .Illustrative Example: Relief From Royalty Method .152 .Additional Considerations for Relief From Royalty Method .153 .Application of Decision Tree Analysis to IPR&D Assets .154–.170 .Overview .154 .Pharmaceutical IPR&D Valuation Example: Decision Tree Analysis .155–.168 .6 Valuation of In–Process Research and Development Assets continued Summary of Decision Tree Analysis .169–.170 .Other Methods .171–.172 .Valuation Report Considerations .173–.184 .Identification and Description of IPR&D Assets .176 .Valuation of IPR&D Assets .177–.183 .Reconciliation of Value Estimates .184 .Comprehensive Example .185–.200 .Overview .185–.186 .Trade Name .187–.188 .Patents .189–.190 .Customer Relationships .191–.192 .Developed Technology .193–.194 .IPR&D .195–.197 .Additional Analysis .198–.199 .Schedules .200 .Glossary .Index of Pronouncements and Other Technical Guidance .Subject Index

  • ISBN: 978-1-9373-5278-3
  • Editorial: John Wiley & Sons
  • Encuadernacion: Rústica
  • Páginas: 208
  • Fecha Publicación: 30/11/2016
  • Nº Volúmenes: 1
  • Idioma: Inglés